Authors: Schwaab, T Weiss, JE Schned, AR Barth, RJ

Citation: T. Schwaab et al., Dendritic cell infiltration in colon cancer, J IMMUNOTH, 24(2), 2001, pp. 130-137

Authors: Schwaab, T Lewis, LD Cole, BF Deo, Y Fanger, MW Wallace, P Guyre, PM Kaufman, PA Heaney, JA Schned, AR Harris, RD Ernstoff, MS

Citation: T. Schwaab et al., Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI Xanti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu, J IMMUNOTH, 24(1), 2001, pp. 79-87

Authors: Schwaab, T Heaney, JA Schned, AR Harris, RD Cole, BF Noelle, RJ Phillips, DM Stempkowski, L Ernstoff, MS

Citation: T. Schwaab et al., A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha 2b therapy in patients with metastatic renal cell carcinoma: Clinical outcome and analysis of immunological parameters, J UROL, 163(4), 2000, pp. 1322-1327

Authors: Schwaab, T Atzpodien, J

Citation: T. Schwaab et J. Atzpodien, Renal cell carcinoma, STRATEGIES IN ADJUVANT THERAPY, 2000, pp. 133-152

Authors: Schwaab, T Schned, AR Heaney, JA Cole, BF Atzpodien, J Wittke, F Ernstoff, MS

Citation: T. Schwaab et al., In vivo description of dendritic cells in human renal cell carcinoma, J UROL, 162(2), 1999, pp. 567-573